Showing results (41-50 of 435) with videos related to

Sort By:
Pageof 44
British Journal of Haematology|August 26, 2009
TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3John D Shaughnessy, Yiming Zhou, Jeff Haessler, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|May 5, 2007
Gene expression profiling defines a high-risk entity of multiple myelomaFeng-Huang Zhan, Bart Barlogie, Shaughnessy John D
Seminars in Oncology|January 10, 2003
High-dose therapy and immunomodulatory drugs in multiple myelomaBart Barlogie, John Shaughnessy, Maurizio Zangari, et al.
British Journal of Haematology|April 26, 2002
Optimizing dendritic cell-based immunotherapy in multiple myelomaQing Yi, Raman Desikan, Bart Barlogie, et al.
Blood|April 13, 2012
Prediction of cytogenetic abnormalities with gene expression profilesYiming Zhou, Qing Zhang, Owen Stephens, et al.
International Journal of Hematology|January 5, 2020
Hemophagocytic relapsed intramedullary plasmacytomaTarek H Mouhieddine, Bart Barlogie, Julie Teruya-Feldstein
Pageof 44